Drugs / Apaziquone
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01373398 | May 2011 → Feb 2012 | urinary bladder cancer | Handok Inc. | Completed | No outcome recorded |
| Phase 35 trials · 2 missed | ||||||
| Phase 3 | NCT03224182 | Aug 2017 → Sep 2019 | urinary bladder cancer | Spectrum Pharmaceuticals, Inc | Terminated | No outcome recorded |
| Phase 3 | NCT02563561 | Oct 2015 → Mar 2017 | urinary bladder cancer | Spectrum Pharmaceuticals, Inc | Terminated | No outcome recorded |
| Phase 3 | NCT01469221 | Jan 2012 → Apr 2013 | urinary bladder cancer | Spectrum Pharmaceuticals, Inc | Terminated | No outcome recorded Stop: Business |
| Phase 3 | NCT00598806 | Aug 2007 → Jan 2012 | urinary bladder cancer | Spectrum Pharmaceuticals, Inc | Completed | Missed primary |
| Phase 3 | NCT00461591 | Apr 2007 → Jan 2012 | urinary bladder cancer | Spectrum Pharmaceuticals, Inc | Completed | Missed primary |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT00141531 Comparator | Jul 2005 → Dec 2009 | urinary bladder neoplasm | Spectrum Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 3 | NCT01410565 Comparator | Jul 2011 → Mar 2014 | urinary bladder cancer | Spectrum Pharmaceuticals, Inc | Terminated | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Apaziquone | “A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)” NCT03224182 ↗ |
| Known as | EO9 | “EO9(Apaziquone)” NCT01373398 ↗ |
| Known as | Qapzola | “A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)” NCT03224182 ↗ |
| Route | Other | “A single intravesical dose of Apaziquone 4mg in 40ml instilled into the bladder post-TURBT” NCT00461591 ↗ |